1. Efficacy and tolerance of cetuximab in combination with 5 FU plus irinotecan based chemotherapy in metastatic squamous cell anal carcinoma. Issue 3 (March 2023) Authors: Valery, M.; Cervantes, B.; Smolenschi, C.; Boilève, A.; Boige, V.; Malka, D.; Hollebecque, A.; Ducreux, M. Journal: Digestive and liver disease Issue: Volume 55:Issue 3(2023) Page Start: 407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗